SUBSCRIBE
SUBSCRIBE

89bio

555 Montgomery Street, Suite 1500
San Francisco, CA 94111
Tel: (415) 432-9270
Visit website
Email Us
NEWS
Drug Development
Clinical Catch-Up: August 2-6
It was a busy week for clinical trial announcements. Take a look.
August 6, 2021
 · 
7 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
June 5, 2025
 · 
1 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 9, 2025
May 12, 2025
 · 
1 min read
Press Releases
89bio to Participate in Upcoming May 2025 Investor Conferences
May 7, 2025
 · 
1 min read
Press Releases
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
May 2, 2025
 · 
9 min read
Press Releases
89bio to Participate in the Leerink Partners Global Healthcare Conference
March 4, 2025
 · 
1 min read
Press Releases
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
February 28, 2025
 · 
10 min read
Press Releases
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2025
February 7, 2025
 · 
1 min read
Press Releases
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 3, 2025
 · 
2 min read
Press Releases
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
 · 
5 min read
Press Releases
89bio Provides Business Update and Outlook for 2025
January 14, 2025
 · 
5 min read
Load More